Home
Off-the-shelf
Humanized mice (target-specific)
genO‑hIgE/hFcεR1
Humanized mice (target-specific)

Humanized genO‑hIgE/hFcεR1 mouse model

Use the genO‑hIgE/hFcεR1 mouse model to successfully screen for innovative therapeutics for allergy, asthma and other IgE-mediated diseases.

Contact Us

Applications of the genO‑hIgE/hFcεR1 mouse model

Useful applications for researchers working in immuno-inflammation and allergic diseases: 

  • Assess the efficacy of IgE-targeting therapeutics
    • Test therapeutics that block anaphylaxis (passive or active) and help controling asthma
  • Develop models of Passive Cutaneous Anaphylaxis (PCA), OVA hypersensitivity and Passive systemic anaphylaxis (PSA)
  • Investigate the mode of action (MoA) of various compounds and understand their therapeutic potential

 

 Features

  • Human-like cellular distribution (i.e., mast cells, basophils, monocytes/DCs, Langerhans cells, and eosinophils) of the FcεR1 receptor
  • Physiological regulation and expression of the chimeric IgE/FcεR1 complex
  • Preservation of ligand-receptor interaction
  • Preservation of the Ig class switching mechanism
  • Human IgE is present, but at low levels
  • Fully functional mouse immune system
  • Lack of expression of the murine target genes

Clients

Carterra

Scientific articleScientific articlePosterPoster

IgGenix

Scientific articleScientific articlePosterPoster

Ambiotis

Scientific articleScientific articlePosterPoster

Seismic Therapeutic

Scientific articleScientific articlePosterPoster

Supply & delivery

  • Breeding facilities in US and Europe
  • Delivery door-to-door worldwide
  • Certified health status from professional breeders

Related resources and publications

Adult-type granulosa cell tumor (AGCT)

castration-resistant metastatic prostate cancer (mCRPC)

CCR8

Chemokine

SIRPα

sirp-alpha

CD137

pulmonary embolism (PE)

osteomyelitis

hyperalgesia

PET imaging

intrauterine growth deficiency

Myopia

ossification

cGAS

cGAS-STING pathway

TFRC

FX-deficiency

muscle-eye-brain disease (MEB)

Tumor microenvironment

primary immunodeficiency (PID)

Oncology

Pharmacology

Neuroscience

Metabolism

Inflammation

Immunology

Respiration

Cardiovascular

Ophthalmology

Nephrology

Musculoskeletal

Hematology

Epigenetics

Development

Endocrinology

Dermatology

Humanization

Rosa26

TET system

Hprt

CreERt2

FLEx

innate immunity

Transgenesis

infection

vision

immune response

dementia

central nervous system (CNS)

taste

transplantation

autoimmunity

thermoregulation

sugar homeostasis

stress

skelet

pulmonary research

nutrition

pain research

muscle research

locomotion

memory

hearing

fat homeostatsis

tissue research

epigentic modification

drugs

cancer research

cell research

behavior

aging

stem cell research

reproductive research

lymphatic system

learning

heart research

gut research

genetic research

exercise

bone research

embryonic development

dental research

blood research

von Willebrand disease (VWD)

X-linked adrenoleukodystrophy (X-ADL)

Vanishing White Matter (VWM) disease

type 2 diabetes (T2D)

ulcerative colitis (UC)

type 1 diabetes (T1D)

thrombosis

thrombocytopenia

systemic lupus erythematosus (SLE)

tauopathy

stenosis

steatohepatitis

spinocerebellar ataxia type 2 (SCA2)

small cell lung cancer

SHORT syndrome

sepsis

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
PosterS
(
0
)
Scientific Articles
(
0
)
CommentarIes
(
0
)
Case studies
(
0
)
No results
Widespread monoclonal IgE antibody convergence to an immunodominant, pro-anaphylactic Ara h 2 epitope in peanut allergy

J Allergy Clin Immunol

Sep 2023
No results
No results
No results

Validation data

Discover related products to

genO‑hIgE/hFcεR1

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
HSA
PK/PD
Fc receptor

genO‑HSA/hFcRn

Double humanized genO‑HSA/hFcRn mouse model as a cutting-edge platform for preclinical development of HSA and FcRn-oriented therapeutics.

HSA
PK/PD
Fc receptor
KO-Rep-Mix

genO‑HSA/hFcRn-RAG1KO

This upgraded, immunocompromised RAG1-/- version of our genO-HSA/hFcRn mouse model allows the assessment of compounds' half-life and anti-tumor efficacy in a human tumor model.

CD4
Inflammation
T-cell receptor

genO‑hCD4

The humanized genO‑hCD4 mouse model allows in vivo efficacy and safety assessment of anti-human CD4 compounds.

‍

FcgR
Fc receptor

genO‑hFcγR

Preclinical humanized Fc-gamma receptor (genO‑hFcγR) model enabling the assessment of Fc receptor pathways targeted therapies.

‍

Inflammation
TNF
Cytokine

genO‑hTNF-α

The genO‑hTNF-α model provides new opportunities for assessment of anti-TNF therapies.

Humanized genO‑hIgE/hFcεR1 mouse model

Get in touch about

Let us know how we can help